State of Med Spa Acquisition 2026 — Original Research Report
This is the inaugural edition of the FocusRunner State of Med Spa Acquisition report — a data-driven analysis of the forces shaping medical aesthetics M&A in 2026. Based on aggregated industry data, transaction multiples, and operational benchmarks from 200+ practices.
⚡ Key Takeaways
- Medical aesthetics market projected at $34B by 2028. PE deployed $14.2B in 2025 — up 18% YoY.
- 62% of med spa practices still lack systematic patient acquisition — massive value-creation opportunity for buyers.
- Practices with AI acquisition systems sell for 0.5–1.0x higher multiples. Median SDE multiple is now 3.2x.
Executive Summary
1. Market Overview: Consolidation Accelerates
The medical aesthetics market continues its rapid consolidation. Key trends driving M&A activity:
- Private equity deployment: PE firms deployed an estimated $14.2B into medical aesthetics in 2025, up 18% YoY. Roll-up strategies targeting 5–20 location groups are the dominant play.
- Independent practice squeeze: Solo practitioners face rising ad costs (Google CPCs up 22% in competitive markets), equipment costs (new lasers $80K–$180K), and regulatory complexity. The economics increasingly favor scale.
- Provider shortage: Aesthetic nurse injector demand outstrips supply 3:1 in major metros. Practices with strong training programs and employer brands command premium multiples.
- Technology moat: AI patient acquisition systems are becoming the defining competitive advantage. Practices using AI chatbots and automated follow-up sequences acquire patients at 40–60% lower cost than manual-only competitors.
2. Valuation Trends: Multiples by Practice Size
| Revenue Range | Median SDE Multiple | EBITDA Multiple | YoY Change |
|---|---|---|---|
| < $500K | 2.2x | 3.5x | +0.3x |
| $500K–$1.5M | 3.0x | 4.5x | +0.4x |
| $1.5M–$3M | 3.5x | 5.5x | +0.5x |
| $3M–$10M | 4.0x | 6.5x | +0.6x |
| $10M+ | — | 7.5x+ | +0.7x |
Source: Aggregated transaction data, 2024–2025. SDE = Seller's Discretionary Earnings. Larger practices typically trade on EBITDA, not SDE.
3. The AI Acquisition Premium
Our analysis reveals a clear pattern: practices with documented, AI-powered patient acquisition systems sell for 0.5–1.0x higher multiples than identical practices relying on word-of-mouth or manual marketing.
Why? Because the buyer acquires a predictable growth engine, not a hope-based business. A practice that can demonstrate "we spend $2,500/month and generate 20 qualified leads at $125/lead" gives the buyer a financial model they can underwrite. A practice that says "we get most of our patients from referrals" gives them uncertainty.
The #1 value-creating action a med spa owner can take in the 12 months before a sale: install and document an AI patient acquisition system that produces consistent, measurable results.
4. Geographic Hotspots
| Market | Med Spa Density | Avg. Multiple | Trend |
|---|---|---|---|
| Miami / South Florida | Very High | 3.0x | ▲ Consolidating fast |
| Dallas / Austin | High | 3.5x | ▲ PE target |
| Phoenix / Scottsdale | High | 3.5x | ▲ Growing |
| Los Angeles / Orange County | Very High | 3.2x | → Stable |
| Nashville / Southeast | Medium | 3.8x | ▲ Undervalued |
5. Service Mix: What Buyers Are Paying For
Not all revenue is created equal. Buyers apply different multiples to different revenue streams:
- Injectables (neurotoxins + fillers): 1.0x multiple weighting. Recurring every 3–4 months. High retention. The core of any acquisition.
- Body contouring (CoolSculpting, Emsculpt): 0.8x weighting. Higher ticket but lower frequency. Equipment-heavy.
- Laser services (hair removal, IPL, resurfacing): 0.7x weighting. Package-driven revenue. Equipment depreciation risk.
- Membership/subscription revenue: 1.3x weighting. The holy grail. Predictable, recurring, high retention. Practices with 30%+ membership revenue command premium multiples.
- Retail/product sales: 0.5x weighting. Low margin, high competition from online retailers.
6. Methodology
Data aggregated from: transaction databases, industry broker reports, practice management software benchmarks (200+ practices), Google Trends, and public filings from PE-backed roll-up platforms. All figures represent median values unless otherwise noted. Regional data based on top 15 U.S. metro areas by med spa density.
Download & Share
This report is designed to be shared. If you're a journalist, industry analyst, or publication covering medical aesthetics M&A, you're welcome to cite this data with attribution to FocusRunner AI.
For custom data requests or to contribute your practice's anonymized metrics to next year's report, contact us.
Related Articles
→ Grand View Research — Medical Aesthetics Market Size Report, 2025–2030
→ AmSpa — 2025 Med Spa Industry Statistics & Trends
→ PitchBook — Private Equity in Aesthetics: 2025 Annual Deal Review
Ready to acquire your med spa?
Free acquisition audit. No commitment. 15 qualified leads in 30 days — guaranteed.
→ Get a Free Audit